SequelSEC

VSEE HEALTH, INC. VSEE

Services-Health Services · CIK 0001864531 · Fiscal year ends 1231

Revenue
$14.62M
Fiscal year ended 2025-12-31
Operating income
-$9.58M
Fiscal year ended 2025-12-31
Free cash flow
-$3.48M
Fiscal year ended 2025-12-31

VSEE HEALTH, INC. (VSEE) reported revenue of $14.62M and net income of -$14.71M for the fiscal year ended 2025-12-31. This page shows 3 annual periods of income statement, balance sheet and cash flow figures normalized from VSEE HEALTH, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Health Services.

Income

VSEE HEALTH, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-31
Revenue$14.62M$10.42M$5.77M
Cost of revenue$7.26M$3.24M$1.93M
Gross profit$7.36M$7.18M$3.83M
Operating income-$9.58M-$62.15M-$1.87M
Net income-$14.71M-$57.70M-$3.76M
Research & developmentUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 20.14Mshares 10.21Mshares 10.00M
Pretax income-$14.64M-$59.34M-$1.89M
Income tax expense$13.50K-$1.64M$1.84M
Diluted EPS$-0.73$-5.65$-0.38
Selling, general & administrativeUnavailableUnavailableUnavailable
General & administrative$10.04M$6.55M$1.20M
Selling & marketingUnavailableUnavailableUnavailable

Balance

VSEE HEALTH, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-31
Cash & equivalents$5.05M$326.12K$118.73K
Total assets$22.41M$19.99M$805.79K
Current assets$8.37M$3.02M$802.13K
Total liabilities$16.96M$20.01M$5.11M
Current liabilities$16.24M$19.01M$5.11M
Total equity incl. NCI$5.45M-$18.49K-$4.30M
Temporary (mezzanine) equityUnavailableUnavailable$1.28M
InventoryUnavailableUnavailableUnavailable
Accounts receivable$2.24M$1.72M$603.48K
Goodwill$4.92M$4.92MUnavailable
Long-term debt$593.94K$593.94K$220.00K
Accounts payable$5.31M$4.28M$416.80K

Cash flow

VSEE HEALTH, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-31
Operating cash flow-$3.45M-$5.79M-$632.60K
Capital expenditures$29.93K$55.27K$4.34K
Investing cash flow-$29.93K-$26.14K-$4.34K
Financing cash flow$8.42M$6.02M$525.00K
Net change in cash$4.94M$207.38K-$111.93K
Stock-based compensationUnavailableUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailable
Common share repurchases$44$5.15K$6.80M
Depreciation & amortization$2.59M$1.32M$678

Derived

VSEE HEALTH, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-31
Free cash flow-$3.48M-$5.84M-$636.93K
Gross margin50.3%68.9%66.5%
Operating margin-65.6%-596.4%-32.5%
FCF margin-23.8%-56.1%-11.0%
SBC / revenueUnavailableUnavailableUnavailable
Current ratio0.51x0.16x0.16x
Revenue YoY growth40.3%80.7%Unavailable
Net margin-100.6%-553.7%-65.3%
R&D / revenueUnavailableUnavailableUnavailable
CapEx / revenue0.2%0.5%0.1%
Long-term debt / equity0.11xUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open VSEE in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-15View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q/A · Filed 2025-11-20View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-10-15View SEC filing

Companies in the same industry

Reconciliation checks needing review

1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2023-12-31

Difference 1281957 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.